Dalfampridine Tablet, Film Coated, Extended Release
Product Images NDC 0591-2533

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 0591-2533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2 (Image 1)

An illustration showing the Cockcroft-Gault equation for estimating creatinine clearance (CrCl). The formula calculates CrCl using age, weight in kilograms, serum creatinine in mg/dL, and a constant factor 72.*

FDA Label Image

Chemical Structure (Image 2)

Chemical structure of dalfampridine, showing a pyridine ring with an amino group attached.*

FDA Label Image

Figure 1 (Image 3)

A bar chart comparing the percentage of patients achieving various thresholds of average percent increase in walking speed from baseline. Data compares placebo (N=72) to Dalfampridine extended-release tablets 10 mg twice daily (N=224). The y-axis shows patient percentages from 0% to 100%, while the x-axis shows thresholds from ≥0% up to ≥60%. P values indicate statistical significance at each threshold.*

FDA Label Image

Figure2 (Image 4)

A bar chart comparing the percentage of patients achieving different thresholds of average percent increase in walking speed from baseline. The chart shows two groups: placebo (N=118) and Dalfampridine extended-release tablets 10 mg twice daily (N=119). P values are displayed at each threshold, indicating statistical comparisons between the two groups for increases of 0%, 10%, 20%, 30%, 40%, 50%, and 60% in walking speed.*

FDA Label Image

New (Image 5)

Label for Dalfampridine Extended-release Tablets 10 mg from Actavis Pharma, Inc. The label states the quantity is 60 film-coated, extended-release tablets for oral use. It includes storage instructions, warnings to keep out of reach of children, and manufacturer information with Teva Pharmaceuticals USA, Inc. logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.